Ethical Issues in a Drug Information Center

Abstract

Spanish

French

The frequency and nature of ethical issues faced by pharmacists have not been well documented. To address these issues a retrospective study of the potential ethical problems encountered by pharmacists in a drug information center was conducted. Of the 744 calls received over a 13-month period, 50 raised ethical issues. Consumer calls were more likely to raise ethical issues than were health-provider calls. The calls mainly fell into five categories: drug identification, assessment of a physician's recommendations for consumers, conflict between callers' needs and legal or public-health considerations, therapeutic issues in the pharmacist-patient relationship, and paternalistic treatment of “difficult” callers. These questions raised ethical issues related to confidentiality, truth telling, and pharmacists' societal obligations. Pharmacists may confront an increased number of ethical issues as more drug information centers provide consumer services. Although there is no empirical evidence regarding pharmacists' ability to deal with ethical issues, there are reasons to believe that training in medical ethics will better equip pharmacists to recognize, analyze, and resolve ethical dilemmas.

Keywords

medical ethics drug information center pharmacy education

Get full access to this article

View all access options for this article.

References

Mappes

Zembatty

, eds. Biomedical ethics. New York: McGraw-Hill, 1981.

President's Commission for the Study of Ethical Problems in Medicine and Biomedical Research. Deciding to forego life-sustaining treatment. Washington, DC: U.S. Government Printing Office, 1983.

Wanzer

Adelstein

Cranford

. The physician's responsibility toward the hopelessly ill patient. N Engl J Med 1984; 310: 955–9.

Kornfeld

. Doctor's dilemma: what truth for which patient at what time? CA 1978; 28: 256.

Walters

. The principle of medical confidentiality. In: Mappes

Zembatty

, eds. Biomedical ethics. New York: McGraw-Hill, 1981: 116–9.

Buerki

. Teaching a professional ethics: a historical perspective. Am J Pharm Educ 1984; 48: 395–6.

Amerson

Wallingford

. Twenty years' experience with drug information centers. Am J Hosp Pharm 1983; 40: 1172–8.

Evans

. The state of the art and future directions of drug information centers. Pharm Intern 1985; 14: 74–9.

Amerson

. Drug information centers: an overview. Drug Inf J 1986; 20: 173–8.

10.

Grace

Wertheimer

. Judgmental questions processed by a drug information center. Am J Hosp Pharm 1975; 32: 903–4.

11.

Beauchamp

Childress

. Principles of biomedical ethics. 2nd ed. New York: Oxford Publishing, 1983: 3–19.

12.

Clouser

. Bioethics. In: Reich

, ed. Encyclopedia of bioethics. New York: Macmillan, 1979: 115–27.

13.

Ladd

. The task of ethics. In: Reich

, ed. Encyclopedia of bioethics. New York: Macmillan, 1979: 400–7.

14.

Schroeder

. Frequency of ethical dilemmas in a medical inpatient service. Arch Intern Med 1981; 141: 1062–4.

15.

Dombrowski

Visconti

. National audit of drug information centers. Am J Hosp Pharm 1985; 42: 819–26.

16.

Talley

. Drug information for consumers (editorial). Am J Hosp Pharm 1980; 37: 1195.

17.

Sigell

Piascik

Parker

. Consumer focus of a university drug and poison information center. Am J Hosp Pharm 1980; 37: 1206–10.

18.

Montagne

Clute

McKernnell

. A statewide decentralized public drug information center. Am J Hosp Pharm 1980; 37: 1211–5.

19.

Conner

Murphrey

Sawyer

. Information services for consumers and health professionals. Am J Hosp Pharm 1980; 37: 1215–9.

20.

Lee

Gumper

Okas

. Pilot project for a statewide public drug information service (letter). Am J Hosp Pharm 1980; 37: 1176.

21.

Gallo

Gentling

. Substance abuse questions answered by a drug information service. Am J Hosp Pharm 1986; 43: 1759–60.

22.

Clark

White

Hamner

. Liability of drug information centers. US Pharm 1982; 7: 39–42, 56.

23.

Cough

Healey

Rupp

. Poison control centers, from aspirin to PCBs and the scarlet runner bean: a study of legal anomaly and social necessity. Santa Clara Law Rev 1983; 23: 791–809.

24.

Fink

. Liability of the pharmacist as a therapeutic consultant. Am J Hosp Pharm 1981; 38: 218–22.

25.

Brushwood

Simonsmeier

. Drug information for patients—duties of the manufacturer, pharmacist, physician, and hospital. J Leg Med 1986; 7: 279–341.

26.

Special session: can a professional ethos be taught?

Am J Pharm Educ 1984; 48: 395–409.

27.

Smith

. Instruction in ethics in schools of pharmacy. Am J Pharm Educ 1981; 45: 14–7.

28.

Aroskar

Bartlett

. When doctor and nurse disagree. In: Basson

, ed. Troubling problems in medical ethics: the third volume in a series on ethics, humanism, and medicine. New York: Alan R. Liss, 1981: 183–205.

29.

Jameton

. The nurse: when roles and rules conflicts. Hastings Cent Rep 1977; 7: 22–3.

30.

Agich

. Evaluating medical ethics teaching. Soc Health Hum Values Notes 1985;Sept: 3–4.

31.

Jonsen

. A concord in medical ethics. Ann Intern Med 1983; 99: 261–4.